Cell Injury and Protection in the Gastrointestinal Tract

Emerging research in gastrointestinal diseases.- I. General Mechanisms of Gastrointestinal Injury and Protection.- Analyses of pathogenic elements involved in gastric lesions induced by indomethacin in rats.- NO-NSAID: a novel class of anti-inflammatory drugs with reduced gastrointestinal and renal toxicity.- Gastric mucosal preventive effects of prostacyclin and ?-carotene, and their biochemical effects in rats treated with ethanol and HCl at different doses and time intervals after administration of necrotizing agents.- Reduction in gastric bicarbonate secretory response induced by NG-nitro-L-arginine methyl ester following repeated administration in rats.- Role of basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) in ulcer healing.- The response of odontoblasts to injury to epithelial integrity: review.- Analysis of adrenoceptor- and related receptor-mediated gastric Cytoprotection.- II. Cell Injury and Protection in the Stomach.- The effect of intragastric capsaicin and resiniferatoxin on the indomethacin-induced gastric mucosal damage in rats.- A comparative study on the adenine nucleotide metabolism of acid-dependent and non-acid-dependent acute gastric mucosal injury in the rats.- Morphological aspects of BPC-peptide protection in ethanol-induced gastric lesions in rats.- Inhibitory effect of omentopexy on experimental chronic gastric antral ulcer formation.- Effect of suramin on ethanol-induced gastric mucosal injury: relationship between tissue distribution and severity of damage.- Effects of ranitidine, omeprazole and vagotomy on rat gastric mucosal phospholipids.- Are phospholipids involved in the gastroprotective capacity of avocado?.- Transmucosal potential difference as a marker of Helicobacter pylori-induced gastric mucosalbarrier damage.- Impaired gastric mucosal defence in Helicobacter pylori-related Conditions.- The role of cysteine and serine proteases in gastric carcinogenesis and their prognostic impact in gastric cancer.- Inhibition of rabbit gastric epithelial restoration by a water extract of Helicobacter pylori: evidence using a cultured cell model.- III. Cell Injury and Protection in Small Intestine and in the Large Bowel.- Zinc sulphate healing effects on cysteamine-induced duodenal ulcer in the rat.- Endogenous vasopressin damages duodenal mucosa during haemorrhagic shock in rats.- The vascular event as a target in changes of indomethacin-induced gastrointestinal mucosal damage after acute surgical and ‘chemical’ vagotomy in rats.- Involvement of corticotropin releasing factor (CRF) and vasopressin (AVP) in stress-induced exacerbation of experimental colitis in rats.- Protective effect of trapencaine in acetic acid-induced colitis in rats.- Pentadecapeptide BPC 157 beneficially influences the healing of colon—colon anastomoses in rats.- Cysteine and serine proteases in duodenal ulcer.- IV. Cell Injury and Protection in the Liver and in the Pancreas.- Treatment of chronic liver disease. Do cytoprotective agents interfere with drug-metabolizing activity?.- Recombinant interferon-?2btreatment for chronic hepatitis C. A prospective multicentre study in Hungary.- Immunological features and the effect of interferon treatment in chronic hepatitis C.- Long-term interferon-?2btherapy in chronic hepatitis B. A prospective multicentre study in Hungary.- New emphasis in the treatment of pancreatic insufficiency.- Metabolic responses to open and laparoscopic cholecystectomy.- Octreotide in the prevention of increased serum amylase after endoscopic cholangiopancreatography. Aprospective, randomized and multicenter study in Hungary.- V. Cell Injury and Protection of the Premalignant Status and Malignant Diseases in the Gastrointestinal Tract.- Genetic polymorphisms of CYP1A1, CYP2E1, and GSTM1 genes: susceptibility to colon cancer.- Serum carotenoids and malignant gastrointestinal diseases in patients.